Institutions / Broadwood Capital Inc

Broadwood Capital Inc

CIK 1278387 · Institution · as of Mar 31, 2026
Portfolio value
$1.42B
Positions
6
As of
Mar 31, 2026

Portfolio trend

Portfolio value

$1.42B-14.3%
$1.65B$1.54B$1.42BQ4 '25Q1 '26

Positions

6-14.3%
776Q4 '25Q1 '26

Top holdings

Mar 31, 2026
CompanyClassValueShares% of portfolio
Monster Beverage Corp—$587.49M8,107,79641.4%
Staar Surgical Co—$301.52M16,123,84221.3%
Axon Enterprise Inc—$294.52M693,50420.8%
iShares Tr—$117.78M474,9208.3%
Lineage Cell Therapeutics, Inc.LCTXCommon Stock$78.31M49,560,9925.5%
Insight Molecular Diagnostics Inc.IMDXCommon Stock$39.14M11,931,8392.8%

Activity

Mar 31, 2026View full history →
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.
DateActionCompanyValueShares ΔPosition afterImpact
Q1 2026
as of
AddStaar Surgical Co$20.65M+1.1M
+7.35%
16,123,842
21.25% of portfolio
medium
Q1 2026
as of
TrimMonster Beverage Corp$-6.61M-91K
-1.11%
8,107,796
41.41% of portfolio
medium
Q1 2026
as of
AddIMDX
Insight Molecular Diagnostics Inc.
Common Stock
$1.71M+522K
+4.57%
11,931,839
2.76% of portfolio
low
Q1 2026
as of
ExitSER
Serina Therapeutics, Inc.
Common Stock
$-104.2K-54K
-100.00%
—
low